Skip to content

Clinical trials

Phase 4 Hypertension trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 4 Country / region: Russia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20042
20051
20071
20091
20131
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Bristol-Myers Squibb2
Imperial College London1
Istituto Auxologico Italiano1
KRKA1
Novartis1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Sergey V. Nedogoda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension10
Metabolic Syndrome2
Stroke2
Albuminuria1
Dementia1
Diabetic Nephropathies1
Dyslipidemias1
Heart Failure1
Hypercholesterolemia1
Ischemic Attack, Transient1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.